View in EDS

BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer.

Saved in:
Bibliographic Details
Title: BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer.
Authors: Rouanne, Mathieu1,2,3, Adam, Julien4,5, Radulescu, Camélia6, Letourneur, Diane1,7, Bredel, Delphine1, Mouraud, Séverine1, Goubet, Anne-Gaëlle1, Leduc, Marion8,9, Chen, Noah2, Tuan Zea Tan10, Signolle, Nicolas11, Bigorgne, Amélie12,13, Dussiot, Michael12, Tselikas, Lambros1, Susini, Sandrine1, Danlos, François-Xavier1, Schneider, Anna K.11, Chabanon, Roman14,15, Vacher, Sophie16, Bièche, Ivan16
Source: Journal of Clinical Investigation. 6/15/2022, Vol. 132 Issue 12, p1-17. 17p.
Database: Academic Search Ultimate
Description
ISSN:00219738
DOI:10.1172/JCI145666